Farallon Capital Management LLC Arcus Biosciences, Inc. Transaction History

Farallon Capital Management LLC

  • $19.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$17.14 - $25.47 $7.71 Million - $11.5 Million
-450,000 Reduced 45.0%
550,000 $9.43 Million
Q2 2020

Aug 14, 2020
BUY
$13.97 - $36.56 $14 Million - $36.6 Million
1,000,000 New
1,000,000 $24.7 Million
Q2 2018

Aug 14, 2018
SELL
$12.24 - $17.05 $139,805 - $194,745
-11,422 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$15.44 - $17.71 $176,355 - $202,283
11,422 New
11,422 $176,000

Others Institutions Holding RCUS

# of Institutions
200
Shares Held
51.5M
Call Options Held
236K
Put Options Held
141K
View Full List

About Arcus Biosciences, Inc.

RCUS Quotes by TradingView
  • Ticker RCUS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,160,000
  • Market Cap $1.02B
  • Description
  • Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...
More about RCUS
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email